Cargando…
Passive Immunity Should and Will Work for COVID-19 for Some Patients
In the absence of effective antiviral chemotherapy and still in the context of emerging vaccines for severe acute respiratory syndrome-CoV-2 infections, passive immunotherapy remains a key treatment and possible prevention strategy. What might initially be conceived as a simplified donor–recipient p...
Autor principal: | Cimolai, Nevio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atlantis Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432400/ https://www.ncbi.nlm.nih.gov/pubmed/34595467 http://dx.doi.org/10.2991/chi.k.210328.001 |
Ejemplares similares
-
Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19
por: Cimolai, Nevio
Publicado: (2020) -
In pursuit of the right tail for the COVID-19 incubation period
por: Cimolai, Nevio
Publicado: (2021) -
The Complexity of Co-Infections in the Era of COVID-19
por: Cimolai, Nevio
Publicado: (2021) -
Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19
por: Cimolai, Nevio
Publicado: (2021) -
A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19
por: Cimolai, Nevio
Publicado: (2020)